The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 30, 2024

Filed:

Nov. 22, 2021
Applicant:

Qingdao Bolin Biological Technology Co., Ltd., Qingdao, CN;

Inventors:

Yongda Zhao, Qingdao, CN;

Lili Guo, Qingdao, CN;

Lihua Ma, Qingdao, CN;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 39/112 (2006.01); A61P 31/04 (2006.01); A61K 39/02 (2006.01); A61K 39/108 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/0275 (2013.01); A61K 39/0208 (2013.01); A61K 39/0258 (2013.01); A61P 31/04 (2018.01); A61K 2039/521 (2013.01); A61K 2039/70 (2013.01);
Abstract

The present disclosure belongs to the technical field of veterinary biological products, and specifically relates to a triple vaccine for diseases caused byand. In the triple vaccine, antigens are an inactivatedS01 strain, an inactivatedR01 strain and an inactivatedE01 strain. The three strains used in the vaccine have high virulence, disable immunogenicity and disable cross-protection. The prepared vaccine has a desirable safety, causing no local or systemic adverse reactions. In a shelf life test, all indicators of the vaccine are stable and effective after a data analysis of traits, a safety test and an efficacy test; in addition, efficacy test results prove that the inactivated triple vaccine can produce desirable antibodies and relatively desirable attacking protection.


Find Patent Forward Citations

Loading…